Terumo
Terumo Corporation is a Japanese medical technology company that develops, manufactures, and markets medical devices, hospital supplies, and pharmaceuticals. The company operates through three core business divisions, comprising Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. Primary revenue drivers stem from the sale of interventional cardiology catheters, vascular grafts, blood oxygenators, infusion pumps, blood collection systems, and therapeutic cell processing technologies. Key end markets include hospitals, surgical centers, blood banks, biopharmaceutical companies, and clinical healthcare providers worldwide. The firm focuses on medical device technology and minimally invasive surgical tools to improve patient outcomes in complex medical procedures. Terumo maintains a leading global market position in cardiovascular interventional equipment, disposable medical supplies, and automated blood processing technologies. The enterprise is headquartered in Tokyo, Japan, and its common shares are traded on the Prime Market segment of the Tokyo Stock Exchange under ticker 4543.
59 of the funds FundTelligence covers report a position in Terumo.
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 59
Funds holding Terumo
- Danske Invest Japan — Danske Invest · 2.14 % (full portfolio disclosed, August 2026)
- Nordea Japan Portfolio — Nordea Funds · 1.74 % (full portfolio disclosed, September 2026)
- Swedbank Robur Healthcare — Swedbank · 1.65 % (full portfolio disclosed, October 2026)
- Storebrand Japan — Storebrand · 0.57 % (full portfolio disclosed, October 2026)
- Nordea Japanese Sustainable Enhanced — Nordea Funds · 0.42 % (full portfolio disclosed, September 2026)
- Lannebo Marknad Japan — Lannebo · 0.39 % (full portfolio disclosed, June 2026)
- Danske Invest Global Ansvarlig 80 — Danske Invest · 0.34 % (full portfolio disclosed, September 2026)
- Nordea Japan — Nordea Funds · 0.33 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 59 funds holding it.